Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
09/2008
09/25/2008US20080233627 Nicotianamine synthase and gene encoding the same
09/25/2008US20080233620 transformant is obtained by introducing a plurality of enzyme genes involved with polyhydroxyalkanoic acid synthesis such as a polyhydroxyalkanoic acid synthase gene and an acetoacetyl CoA reductase gene into said gene-disrupted yeast
09/25/2008US20080233618 Isolated, purified genetic engineered DNA; culturing a host cell to produce polyketide
09/25/2008US20080233613 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
09/25/2008US20080233611 pairs of orthogonal-tRNAs (O-tRNAs) and orthogonal aminoacyl-tRNA synthetases (O RSs) that do not interact with the host cell translation machinery
09/25/2008US20080233608 Genes and proteins involved in lipid remodeling of gpi-anchored proteins and the use thereof
09/25/2008US20080233595 Method for diagnosing intertility
09/25/2008US20080233581 Nucleic acid; use identifying the enzyme inhibitors which are used as antitumor agents; detection of cells expressing the enzyme
09/25/2008US20080233175 Isolated, synthetic or recombinant nucleic acid encoding a polypeptide having a glucanase, mannanase or xylanase activity, or immunogenic activity and can generate an antibody
09/25/2008US20080233141 Chimera of papillomavirus capsid polypeptide L2; cervical cancers and warts; capsomeres
09/25/2008US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells
09/25/2008US20080233138 Coccidiosis Poultry Vaccine
09/25/2008US20080233119 Modulating death receptor 3 and/or CD30 function; interleukin expression inhibition
09/25/2008US20080233100 Targeted enzymes
09/25/2008US20080233097 different phosphorylation site is the threonine residue in position 123 (Thr123) of mouse or human p38, alpha isoform; diagnostic marker of pathologies mediated by MAPKs
09/25/2008US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy
09/25/2008US20080230399 Fructosylamine Oxidase
09/25/2008US20080229609 Preservation by Vaporization
09/25/2008DE4432627B4 Filtrationseinheit zur Abtrennung von Stoffen mit Membranadsorbern Filtration unit for separating substances with membrane adsorbers
09/25/2008DE102007014742A1 Isoformen der Schweineleber Esterase Isoforms of porcine liver esterase
09/25/2008CA2684321A1 Compositions comprising pkac fragments and uses thereof for inhibiting akt1, p70s6k or abl activity
09/25/2008CA2681265A1 Generation of chemical building blocks from plant biomass by selective depolymerization
09/25/2008CA2680854A1 Treatment method using egfr antibodies and src inhibitors and related formulations
09/25/2008CA2680787A1 Compositions and methods for reducing h2s levels in fermented beverages
09/24/2008EP1972690A1 Desaturase antigen of mycobacterium tuberculosis
09/24/2008EP1972687A1 Polynucleotides and polypeptides of human factor VII gene, SNPs
09/24/2008EP1972686A1 Crystal structure of dicamba monooxygenase (DMO) and uses thereof
09/24/2008EP1971684A1 Chimaeric fusion protein with superior chaperone and folding activities
09/24/2008EP1971683A2 Adenylate cyclase, gene sequence coding for adenylate cyclase, vectors and cells, and the use thereof
09/24/2008EP1814378A4 Casein kinase stress-related polypeptides and methods of use in plants
09/24/2008EP1670906B1 Acylglycerol acyltransferase-like protein mgat-x1 and uses thereof
09/24/2008EP1521771B1 STREPTOCOCCUS PNEUMONIAE PBP2x MINI-PROTEIN AND USES THEREOF.
09/24/2008EP1411128B1 Recombinant viral vectors containing the human urokinase plasminogen activator gene and their utilization in the treatment of hepatic fibrosis
09/24/2008EP1383903B1 Methods for the production of ascorbic acid intermediates in host cells
09/24/2008EP1232254B1 Process for the production of a reversibly inactive acidified plasmin composition
09/24/2008EP1196605B1 Novel cytochrome p450 monooxygenases and their use for oxidizing organic compounds
09/24/2008CN101273140A Compositions of tRNA and uses thereof
09/24/2008CN101273137A Oxidoreductases for the stereoselective reduction of keto compounds
09/24/2008CN101273135A Plants with increased hyaluronan production
09/24/2008CN101273129A Recombinant vector capable of increasing secretion of koji mold protease
09/24/2008CN101273126A 基因sms 27 Gene sms 27
09/24/2008CN101273125A Method for production of enzyme
09/24/2008CN101273120A Method of producing fungal culture
09/24/2008CN101272693A Process for production of fermented milk and fermented milk beverage/food
09/24/2008CN101270375A Technique for preparing 1,3-diglyceride with enzyme in tert-butanol system
09/24/2008CN101270362A Novel serine protease genes related to DPPIV
09/24/2008CN101270351A Method for purifying velardon by using metallic affinity membrane
09/24/2008CN101270347A High-temperature and strong base resistant clausii bacillus cereus, excretive proteolytic enzyme and preparation
09/24/2008CN101270339A Cultivation method for saccharomycete excreting expression proteolytic enzyme
09/24/2008CN100420755C Improvement in homogeneous enzymatic assay and H S detecting
09/24/2008CN100420753C Expression-regulating sequences and expression products in field of filamentous fungi chrysosporium
09/24/2008CN100420747C Method for making insertional mutations
09/24/2008CN100420745C Preparation of hybrid tumour cell expression gene engineering urokinase zymogen
09/24/2008CN100420744C Beta-mannase, its expression and special engineering bacterium
09/24/2008CN100420743C Probiotic composite enzyme production method
09/24/2008CN100420735C Fetid aspergillic strain and uses
09/23/2008US7427698 Transgenic cell transformed with polynucleotide to increase drought tolerance
09/23/2008US7427696 Transcription factor stress-related proteins and methods of use in plants
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427670 Cytochrome P450 24 (CYP24) monoclonal antibody and methods and uses thereof
09/23/2008US7427667 monoclonal; humanized; fragments; labeled
09/23/2008US7427666 Antibody directed against a ubiquitin-specific protease occurring in the brain
09/23/2008US7427659 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction
09/23/2008US7427608 Protection against and treatment of hearing loss
09/23/2008US7427593 Methods of making triacylglycerol using phospholipid:Diacylglycerol acyltransferase
09/23/2008US7427592 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
09/23/2008US7427591 Suppression of immune response via inhibition of cathepsin S
09/23/2008US7427498 Composition, methods and reagents for the synthesis of a soluble form of human PHEX
09/23/2008US7427493 Recombinant genes for polyketide modifying enzymes
09/23/2008US7427484 Polypeptides, nucleic acids; gene codes; antibiotic, immunosuppressants; identifying a novel secondary metabolite biosynthesis gene cluster in a fungus
09/23/2008US7427482 screening for nucleotide sequences coding enzymatic polypeptide associated with purine nucleotide biosynthesis for use as cancer diagnositic markers; antiproliferative/antitumor agents
09/23/2008US7427478 Beta-secretase enzyme compositions and methods
09/23/2008US7427399 Antibodies and related molecules that bind to 161P2F10B proteins
09/23/2008CA2445687C Compositions, methods and systems for the discovery of enediyne natural products
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2346797C Process for recovering heterologous polypeptides from bacterial cells
09/23/2008CA2177997C Enzyme stabilization by block-copolymers
09/23/2008CA2143125C Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
09/18/2008WO2008113041A2 Process for producing low molecular weight hydrocarbons from renewable resources
09/18/2008WO2008112459A2 Alkaliphilic bacillus species a-amylase variants, compositions comprising a-amylase variants, and methods of use
09/18/2008WO2008111628A2 Alkaline protease
09/18/2008WO2008111613A1 Endoglucanase ppce and cellulase preparation containing the same
09/18/2008WO2008111507A1 Modified glucosamine-6-phosphate synthase
09/18/2008WO2008110603A2 Concentrate of protein c containing protein s, its preparation and use
09/18/2008WO2008110513A1 Thermostable asparaginases
09/18/2008WO2008110498A1 Solubilization of protease crystals in fermentation broth
09/18/2008WO2008095033A3 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
09/18/2008WO2008090148A3 Improvement of cell growth
09/18/2008WO2008089339A3 Oligosaccharide conjugates for cellular targeting
09/18/2008WO2008060596A9 Enhanced protein production in t. reesei by co-expression of selected genes
09/18/2008WO2008036970A3 Insulin-degrading enzyme mutants and methods of use
09/18/2008US20080229457 S-adenosyl-l-methionine synthetase promoter and its use in expression of transgenic genes in plants
09/18/2008US20080229455 Using vector transformation to generate plant with enhanced carbohydrate content; improving fruit sweetness
09/18/2008US20080229446 Expression vector comprising nucleotide sequences coding isomerase for use in generating plants with enhanced isoprenoid biosynthesis
09/18/2008US20080227966 Expression vector comprising nucleotide sequences coding glyphosate resistant lyase for use in generation of herbicide resistant plants; controlling weed pest in transgenic crop field
09/18/2008US20080227872 A polyoxyethylene glycol with an end group 1-benzotriazolylcarbonate ester; reacted with lysine to form a water-soluble and non-peptidic to form a biologically active polymer conjugate; one step preparation; phosgene-free; drug delivery; bioavailability; protease resistant; nonimmunogenic; quality
09/18/2008US20080227826 Such as (S)-2-(Dimethylamino)ethyl-1-(4-(2-aminophenylcarbamoyl)-phenyl)pyrrolidin-3-ylcarbamate for treating cell proliferative disorders
09/18/2008US20080227739 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants
09/18/2008US20080227701 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
09/18/2008US20080227661 Mutant reverse transcriptase and methods of use